Datasets:

PatSnap
/

drug-deal

deal_title stringlengths 15 233	data_source listlengths 1 6	principle_org listlengths 1 3 ⌀	partner_org listlengths 1 4 ⌀	deal_project listlengths 1 9 ⌀	deal_type listlengths 1 3 ⌀	deal_value listlengths 1 4 ⌀	territory_included listlengths 1 23 ⌀
GSK exercises option on Anacor’s novel antibiotic for the treatment of gram-negative infections	[ "News", "Company_Website" ]	[ "Anacor Pharmaceuticals" ]	[ "葛兰素史克制药" ]	[ { "name": " GSK2251052", "type": "Drug" } ]	[ "许可" ]	[ { "origin_value": "15百万美元", "type": "upfront_payment", "unit": "million dollars", "value": "15.00" } ]	null
ViVerita Therapeutics Announces Research Collaboration with Boehringer Ingelheim to Accelerate Discovery of Novel Cancer Targets	[ "PRNewswire" ]	[ "ViVerita Therapeutics Inc" ]	[ "Boehringer Ingelheim" ]	[ { "name": "Novel Cancer Targets", "type": "Technology/Platform" } ]	[ "Collaboration" ]	null	null
Ligand Pharmaceuticals acquires Ab Initio Biotherapeutics	[ "NEWS" ]	[ "Ab Initio Biotherapeutics" ]	[ "Ligand Pharmaceuticals" ]	[ { "name": "Ab Initio Biotherapeutics", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "12,000,000 USD", "type": "total_value", "unit": "million dollars", "value": "12.00" } ]	null
海和药物成功召开德立替尼AL3810-202胸腺癌关键性II b期临床试验全国研究者会议	[ "News" ]	[ "中国科学院上海药物研究所" ]	[ "上海海和药物研究开发股份有限公司" ]	[ { "name": "Lucitanib", "type": "Drug" } ]	[ "合作" ]	null	[ "中国（含中国内地、香港、澳门、台湾）" ]
Volastra Therapeutics Announces Drug Discovery Collaboration with Bristol Myers Squibb	[ "News" ]	[ "Volastra Therapeutics" ]	[ "百时美施贵宝制药" ]	[ { "name": "CINtech platform", "type": "Technology/Platform" } ]	[ "合作" ]	[ { "origin_value": "1100百万美元", "type": "milestone_payment", "unit": "million dollars", "value": "1100.00" }, { "origin_value": "30百万美元", "type": "upfront_payment", "unit": "million dollars", "value": "30.00" } ]	null
Bio-Techne and Regulus collaborate to conduct biomarker analysis for RGLS-4326 in ADPKD.	[ "NEWS" ]	[ "Bio-Techne Corp" ]	[ "Regulus Therapeutics Inc" ]	[ { "phase": "Phase 1 Clinical", "name": "RGLS-4326", "type": "Drug" } ]	[ "合作" ]	null	null
J&J inks an $835M RNA deal to develop autoimmune drugs with Isis	[ "NEWS", "Company_Website", "Company_Website", "Company_Website" ]	[ "Isis" ]	[ "Johnson & Johnson", "Janssen Biotech, Inc." ]	[ { "phase": "Preclinical", "name": "IONIS-JBI1-2.5Rx", "type": "Drug" }, { "phase": "Pending", "name": "ION253", "type": "Drug" }, { "name": "new drugs for autoimmune diseases of the gastrointestinal tract", "type": "Drug" } ]	[ "License" ]	[ { "origin_value": "$800 million", "type": "milestone_payment", "unit": "million dollars", "value": "800.0000" }, { "origin_value": "$35 million", "type": "upfront_payment", "unit": "million dollars", "value": "35.0000" } ]	[ "global" ]
Maruho and Astellas Enter License Agreement for the Development and Commercialization of a Topical Formulation of JAK Inhibitor peficitinib for Treatment	[ "News" ]	[ "安斯泰来制药" ]	[ "Maruho" ]	[ { "phase": "Phase 3 Clinical", "name": "peficitinib", "type": "Drug" } ]	[ "许可" ]	null	[ "Global" ]
Adimab Initiates New Therapeutic Discovery Partnership with Innovent	[ "NEWS", "NEWS" ]	[ "Adimab, LLC" ]	[ "Innovent" ]	[ { "name": "an antibody-based therapeutic program", "type": "Drug" } ]	[ "合作" ]	null	[ "worldwide" ]
AgeX Therapeutics and Sernova to Collaborate to Engineer Universal Locally Immune Protected Cell Therapies for Type I Diabetes and Hemophilia A	[ "News" ]	[ "AgeX Therapeutics" ]	[ "Sernova" ]	[ { "name": "UniverCyte(TM) gene technology", "type": "Technology/Platform" } ]	[ "许可" ]	null	null
Biocon and Equillium entered into an agreement to terminate their collaboration and license agreement and other agreements relating to itolizumab	[ "Company_Website", "News", "News" ]	[ "Biocon Group" ]	[ "Equillium" ]	[ { "phase": "Approved", "name": "itolizumab", "type": "Drug" } ]	[ "许可", "投资" ]	null	[ "New Zealand", "Australia" ]
Aldeyra Therapeutics acquires Helio Vision	[ "NEWS" ]	[ "Helio Vision" ]	[ "Aldeyra Therapeutics" ]	[ { "name": "Helio Vision", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "24,645,296 USD", "type": "total_value", "unit": "million dollars", "value": "24.65" } ]	null
Alvogen Korea Holdings acquires Alvogen Korea Co., Ltd.	[ "NEWS" ]	[ "Alvogen Korea Co., Ltd." ]	[ "Alvogen Korea Holdings", "Lotus Pharmaceutical" ]	[ { "name": "Alvogen Korea Co., Ltd.", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "23,777,971 USD", "type": "total_value", "unit": "million dollars", "value": "23.78" } ]	null
Adare Pharma Solutions, Inc. acquires Frontida BioPharm, Inc.	[ "NEWS" ]	[ "Frontida BioPharm, Inc." ]	[ "Adare Pharma Solutions, Inc.", "Frazier Management", "Thomas H Lee Partners" ]	[ { "name": "Frontida BioPharm, Inc.", "type": "Company" } ]	[ "企业收购" ]	null	null
Sepracor, Inc. Acquires Exclusive U.S. Rights to Nycomed's ALVESCO(R) HFA and OMNARIS AQ Products as Well as Ciclesonide Pipeline	[ "News" ]	[ "奈科明制药" ]	[ "Sunovion Pharmaceuticals" ]	[ { "phase": "Approved", "name": "ciclesonide", "type": "Drug" } ]	[ "许可" ]	[ { "origin_value": "150百万美元", "type": "upfront_payment", "unit": "million dollars", "value": "150.00" } ]	[ "United States" ]
Immunocore and Genentech enter strategic alliance to develop ImmTACs for multiple cancer targets	[ "NEWS", "NEWS" ]	[ "Immunocore" ]	[ "基因泰克" ]	[ { "phase": "Preclinical", "name": "IMC-C103C", "type": "Drug" } ]	[ "合作" ]	[ { "origin_value": "100百万美元", "type": "total_value", "unit": "million dollars", "value": "100.00" } ]	null
Melt Pharmaceuticals Announces Exclusive Development and License Agreement with Catalent for Its Zydis® Fast-Dissolve Technology for Use in MELT-300 for Needle- and Opioid-Free Procedural Sedation	[ "NEWS" ]	[ "康泰伦特药业" ]	[ "Melt Pharmaceuticals" ]	[ { "name": "Zydis® orally disintegrating tablet fast-dissolve technology", "type": "Technology/Platform" } ]	[ "合作" ]	null	null
Sanofi to acquire Inhibrx, Inc., adding potential best-in-class rare disease asset for Alpha-1 Antitrypsin Deficiency to pipeline	[ "GlobeNewswire", "NEWS", "NEWS", "NEWS" ]	[ "Inhibrx, Inc." ]	[ "Sanofi" ]	[ { "phase": "phase 2 clinical", "name": "INBRX-101", "type": "Drug" }, { "name": "Inhibrx, Inc.", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "$2.196 billion", "type": "total_value", "unit": "million dollars", "value": "2196.00" } ]	null
EUROAPI SA offers to acquire BianoScience GmbH	[ "NEWS" ]	[ "BianoScience GmbH" ]	[ "EUROAPI SA" ]	[ { "name": "BianoScience GmbH", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "10,805,499 USD", "type": "total_value", "unit": "million dollars", "value": "10.81" } ]	null
AtriCure acquires SentreHEART	[ "NEWS", "NEWS" ]	[ "SentreHEART" ]	[ "AtriCure" ]	[ { "name": "SentreHEART", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "281,397,011 USD", "type": "total_value", "unit": "million dollars", "value": "281.40" } ]	null
CRT, Tusk and UCL form immuno-oncology pact	[ "News" ]	[ "Cancer Research Technology" ]	[ "Tusk Therapeutics" ]	[ { "name": "therapeutic antibodies", "type": "Drug" } ]	[ "许可" ]	null	[ "Global" ]
Verve Therapeutics and Acuitas Therapeutics made a Non-Exclusive License Agreement.	[ "NEWS" ]	[ "Acuitas Therapeutics" ]	[ "Verve Therapeutics" ]	[ { "name": "LNP Technology", "type": "Technology/Platform" } ]	[ "合作" ]	null	null
Zymeworks and LEO Pharma Enter into Bispecific Antibody Licensing and Research Collaboration	[ "NEWS" ]	[ "Zymeworks Inc" ]	[ "LEO Pharma A/S" ]	[ { "phase": "Discovery", "name": "bispecific antibodies targeting cytokine-receptor pathways , Zymeworks/Leo", "type": "Drug" } ]	[ "许可" ]	[ { "origin_value": "475 million 美元", "type": "milestone_payment", "unit": "million dollars", "value": "475.00" }, { "origin_value": "480 million 美元", "type": "total_value", "unit": "million dollars", "value": "480.00" }, { "origin_value": "5 million 美元", "type": "upfro...	[ "World" ]
ERT Operating Co. acquires NeuroRx Research, Inc.	[ "NEWS" ]	[ "NeuroRx Research, Inc." ]	[ "ERT Operating Co.", "Clario Holdings, Inc." ]	[ { "name": "NeuroRx Research, Inc.", "type": "Company" } ]	[ "企业收购" ]	null	null
Acticor Biotech: A +60M€ Regional Development and Commercialisation Agreement Signed with China Medical System Holding Limited®	[ "NEWS" ]	[ "Acticor Biotech" ]	[ "China Medical System Holdings Ltd" ]	[ { "phase": "Phase 1 Clinical", "name": "glenzocimab", "type": "Drug" } ]	[ "许可" ]	[ { "origin_value": "71.54 million 美元", "type": "total_value", "unit": "million dollars", "value": "71.54" } ]	[ "Asia" ]
Day One Completes Acquisition of Mersana Therapeutics	[ "GlobeNewswire", "Company_Website" ]	[ "Mersana Therapeutics" ]	[ "Day One Biopharmaceuticals" ]	[ { "name": "Mersana Therapeutics", "type": "Company" }, { "phase": "Phase 1 Clinical", "name": "XMT-2056", "type": "Drug" }, { "phase": "Phase 1 Clinical", "name": "Emi-Le", "type": "Drug" } ]	[ "M&A" ]	[ { "origin_value": "$285 million", "type": "total_value", "unit": "million dollars", "value": "285.0000" } ]	null
SemaThera Enters into a Research Collaboration and Exclusive License Agreement with Roche	[ "News" ]	[ "SemaThera" ]	[ "罗氏制药" ]	[ { "phase": "Preclinical", "name": "novel Semaphorin 3A antagonists", "type": "Drug" } ]	[ "许可" ]	null	null
Orthofix Medical acquires WITTENSTEIN intens	[ "NEWS", "NEWS" ]	[ "WITTENSTEIN intens" ]	[ "Orthofix Medical" ]	[ { "name": "WITTENSTEIN intens", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "18,031,022 USD", "type": "total_value", "unit": "million dollars", "value": "18.03" } ]	null
LabConnect, Inc. acquires A4P Consulting Ltd.	[ "NEWS" ]	[ "A4P Consulting Ltd." ]	[ "LabConnect, Inc." ]	[ { "name": "A4P Consulting Ltd.", "type": "Company" } ]	[ "企业收购" ]	null	null
Breckenridge Pharmaceutical developed a generic version of Ablysinol in partnership with Andersen Pharma Global	[ "PRNewswire" ]	[ "Breckenridge Pharmaceutical, Inc." ]	[ "Andersen Pharma Global" ]	[ { "phase": "Approved", "name": "a generic version of Ablysinol", "type": "Drug" } ]	[ "Collaboration" ]	null	null
Portage Biotech acquires Tarus Therapeutics, Inc.	[ "NEWS" ]	[ "Tarus Therapeutics, Inc." ]	[ "Portage Biotech" ]	[ { "name": "Tarus Therapeutics, Inc.", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "52,200,333 USD", "type": "total_value", "unit": "million dollars", "value": "52.20" } ]	null
RIKEN and Astellas Enter into Worldwide ExclusiveLicensing Agreement for Artificial Adjuvant VectorCell Technology in Oncology	[ "NEWS" ]	[ "RIKEN" ]	[ "Astellas Pharma Inc" ]	[ { "phase": "Phase 1/2 Clinical", "name": "ASP-7517", "type": "Drug" }, { "name": "ASP-0739", "type": "Drug" } ]	[ "许可" ]	[ { "origin_value": "1000 million 日元", "type": "total_value", "unit": "million dollars", "value": "9.41" } ]	[ "World" ]
Medix Biochemica Oy Ab acquires CANDOR Bioscience GmbH	[ "NEWS" ]	[ "CANDOR Bioscience GmbH" ]	[ "DevCo Partners Oy", "Medix Biochemica Oy Ab" ]	[ { "name": "CANDOR Bioscience GmbH", "type": "Company" } ]	[ "企业收购" ]	null	null
SEJONG MEDICAL Co., Ltd. takes a minority stake in Yozma BMTech Co., Ltd.	[ "NEWS", "NEWS" ]	[ "Yozma BMTech Co., Ltd." ]	[ "SEJONG MEDICAL Co., Ltd." ]	[ { "name": "Yozma BMTech Co., Ltd.", "type": "Company" } ]	[ "企业收购" ]	null	null
Fosun Pharma Inches Up After Securing Rights to Innovative Alzheimer's Disease Drug in China	[ "NEWS" ]	[ "NeuCo United" ]	[ "Fosun Pharmaceutical Group", "Fosun Pharma Industry Development" ]	[ { "phase": "Phase 3 Clinical", "name": "AR1001", "type": "Drug" } ]	[ "License" ]	[ { "origin_value": "USD20.9 million", "type": "total_value", "unit": "million dollars", "value": "20.9000" }, { "origin_value": "USD5.6 million", "type": "upfront_payment", "unit": "million dollars", "value": "5.6000" } ]	[ "Chinese mainland, Hong Kong, and Macao" ]
Suan Farma takes a majority stake in Monteloeder SL	[ "NEWS" ]	[ "Monteloeder SL" ]	[ "Suan Farma" ]	[ { "name": "Monteloeder SL", "type": "Company" } ]	[ "企业收购" ]	null	null
海翔药业与万邦德制药就渐冻症新药研发签订合作协议交易总额为1.5亿元	[ "NEWS" ]	[ "万邦德制药" ]	[ "海翔药业" ]	[ { "phase": "Approved", "name": "WP205", "type": "Drug" } ]	[ "Collaboration" ]	[ { "origin_value": "3000万元", "type": "milestone_payment", "unit": "million dollars", "value": "4.3013" }, { "origin_value": "1.5亿元", "type": "total_value", "unit": "million dollars", "value": "21.5066" }, { "origin_value": "1.2亿元", "type": "upfront_payment", "unit"...	null
Nascent Collaborates With Hypospray Pharma on Proprietary Transdermal Delivery System	[ "NEWS" ]	[ "Nascent Biotech, Inc." ]	[ "HypoSpray Pharma" ]	[ { "phase": "discovery", "name": "Transdermal Delivery formulation of Pritumumab", "type": "Drug" } ]	[ "合作" ]	null	null
Isis, Zeneca Enter $40M Pact For Cancer Treatments	[ "NEWS" ]	[ "Isis Pharmaceuticals Inc." ]	[ "Zeneca Pharmaceuticals Inc." ]	[ { "phase": "Discovery", "name": "antisense-based compounds for cancer", "type": "Drug" } ]	[ "Collaboration" ]	[ { "origin_value": "$40 million", "type": "total_value", "unit": "million dollars", "value": "40.0000" } ]	[ "worldwide" ]
Fresenius Kabi completes acquisition of Merck KGaA’s biosimilars business - Fresenius	[ "Company_Website" ]	[ "默克制药" ]	[ "费森尤斯卡比制药" ]	[ { "name": "Merck KGaA’s biosimilars", "type": "Drug" } ]	[ "收购" ]	[ { "origin_value": "545.7百万美元", "type": "milestone_payment", "unit": "million dollars", "value": "545.70" }, { "origin_value": "170.26百万美元", "type": "upfront_payment", "unit": "million dollars", "value": "170.26" } ]	null
Remedium Bio Announces Strategic Collaboration With Lilly to Develop Gene Therapies for Obesity and Type 2 Diabetes	[ "Biospace" ]	[ "Remedium Bio, Inc." ]	[ "Eli Lilly" ]	[ { "phase": "Discovery", "name": "gene therapies for Type 2 diabetes and obesity", "type": "Drug" } ]	[ "Collaboration" ]	null	null
SK Biopharmaceuticals expands radiopharmaceutical therapy portfolio with second in-licensed candidate from Wisconsin Alumni Research Foundation	[ "PRNewswire" ]	[ "Wisconsin Alumni Research Foundation" ]	[ "SK Biopharmaceuticals" ]	[ { "phase": "Preclinical", "name": "WT-7695", "type": "Drug" } ]	[ "License" ]	null	[ "worldwide" ]
Syncona Investment Management Ltd. acquires Freeline Therapeutics Holdings Ltd.	[ "NEWS", "NEWS" ]	[ "Freeline Therapeutics Holdings Ltd." ]	[ "Syncona Ltd.", "Syncona Investment Management Ltd." ]	[ { "name": "Freeline Therapeutics Holdings Plc", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "12,146,462 USD", "type": "total_value", "unit": "million dollars", "value": "12.15" } ]	null
Flex Pharma acquires Salarius Pharmaceuticals LLC	[ "NEWS", "NEWS" ]	[ "Salarius Pharmaceuticals LLC" ]	[ "Flex Pharma" ]	[ { "name": "Salarius Pharmaceuticals LLC", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "36,600,000 USD", "type": "total_value", "unit": "million dollars", "value": "36.60" } ]	null
SIGA Announces TPOXX® Promotion Agreement with Meridian Medical Technologies, Inc. (A Pfizer Company) for International Markets	[ "GlobeNewswire" ]	[ "SIGA Technologies Inc" ]	[ "Meridian Medical Technologies Inc" ]	[ { "phase": "Approved", "name": "tecovirimat , SIGA Technologies", "type": "Drug" } ]	[ "许可" ]	null	[ "World" ]
Haemonetics acquires enicor	[ "NEWS" ]	[ "enicor" ]	[ "Haemonetics" ]	[ { "name": "enicor", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "20,500,000 USD", "type": "total_value", "unit": "million dollars", "value": "20.50" } ]	null
Scinai Immunotherapeutics Ltd. acquires Recipharm Israel Ltd.	[ "NEWS" ]	[ "Recipharm Israel Ltd." ]	[ "Scinai Immunotherapeutics Ltd." ]	[ { "name": "Recipharm Israel Ltd.", "type": "Company" } ]	[ "企业收购" ]	null	null
Reig Jofre contributes its know-how in the development ofbiological vaccines to the innovative consortium of Vaxdyn	[ "NEWS" ]	[ "Reig Jofre Group" ]	[ "Vaxdyn SL" ]	[ { "phase": "Preclinical", "name": "VXD-001", "type": "Drug" }, { "phase": "Preclinical", "name": "VXD-004", "type": "Drug" }, { "phase": "Preclinical", "name": "VXD-002", "type": "Drug" } ]	[ "合作" ]	null	null
An agreement with Fabre-Kramer Pharmaceuticals granting Organon rights to further develop and market gepirone	[ "NEWS" ]	[ "Bristol Myers Squibb Co.", "Mead Johnson Nutrition Co." ]	[ "Fabre Kramer Pharmaceuticals" ]	[ { "name": "Gepirone ER", "type": "Drug" } ]	[ "收购" ]	null	null
Odonate Therapeutics licensed patent rights covering tesetaxel from Daiichi Sankyo.	[ "News" ]	[ "第一三共株式会社" ]	[ "Odonate Therapeutics" ]	[ { "phase": "Phase 2 Clinical", "name": "tesetaxel", "type": "Drug" } ]	[ "许可" ]	null	null
NOXXON Pharma AG Licenses And Assigns Preclinical Spiegelmer Programs To Aptarion	[ "News" ]	[ "TME PHARMA" ]	[ "Aptarion biotech AG" ]	[ { "phase": "Preclinical", "name": "Preclinical Spiegelmer Programs", "type": "Drug" } ]	[ "收购" ]	null	null
Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206	[ "NEWS", "News" ]	[ "Spero Therapeutics Inc" ]	[ "辉瑞制药" ]	[ { "phase": "Phase 1 Clinical", "name": "SPR206", "type": "Drug" } ]	[ "投资", "许可" ]	[ { "origin_value": "80 million 美元", "type": "milestone_payment", "unit": "million dollars", "value": "80.00" } ]	[ "worldwide" ]
Orthocell Ltd. offers to take a minority stake in Marine Biomedical Pty Ltd.	[ "NEWS" ]	[ "Marine Biomedical Pty Ltd." ]	[ "Orthocell Ltd." ]	[ { "name": "Marine Biomedical Pty Ltd.", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "680,977 USD", "type": "total_value", "unit": "million dollars", "value": "0.68" } ]	null
Thermo Fisher Scientific Partners with AstraZeneca to Develop Solid Tissue and Blood-Based Companion Diagnostic Test for Tagrisso	[ "News" ]	[ "阿斯利康制药" ]	[ "Thermo Fisher Scientific" ]	[ { "phase": "Approved", "name": "Tagrisso", "type": "Drug" } ]	[ "合作" ]	null	null
Grand Pharmaceutical (China) Co., Ltd. acquires Jiangsu Shenming Medical Technology Co., Ltd.	[ "NEWS" ]	[ "江苏申命医疗科技有限公司" ]	[ "远大医药" ]	[ { "name": "江苏申命医疗科技有限公司", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "2260万人民币", "type": "total_value", "unit": "million dollars", "value": "3.54" } ]	null
欧林生物与格里菲斯大学GAS项目合作”签约仪式,暨“疫苗开发联合实验室”揭牌仪式在澳大利亚举行	[ "News" ]	[ "Griffith University" ]	[ "成都欧林生物科技股份有限公司" ]	[ { "name": "GAS (Group A streptococcus) 疫苗", "type": "Drug" } ]	[ "许可" ]	null	null
Strata Oncology Announces Expansion of Clinical Collaboration with Pfizer for Strata PATH Trial into Early-Stage Cancer	[ "NEWS" ]	[ "Strata Oncology" ]	[ "Pfizer Inc" ]	[ { "phase": "Approved", "name": "binimetinib", "type": "Drug" }, { "phase": "Approved", "name": "axitinib", "type": "Drug" }, { "phase": "Approved", "name": "encorafenib", "type": "Drug" }, { "phase": "Approved", "name": "talazoparib tosylate", "type": "Dru...	[ "临床合作" ]	null	null
PostEra announces expansion to $610M in their AI drug discovery collaboration with Pfizer	[ "PRNewswire" ]	[ "PostEra" ]	[ "Pfizer" ]	[ { "name": "Antibody-Drug-Conjugate (ADC) program", "type": "Drug" } ]	[ "Collaboration" ]	[ { "origin_value": "$12M", "type": "upfront_payment", "unit": "million dollars", "value": "12.0000" } ]	null
PANTHERx® Rare Selected by Rhythm Pharmaceuticals Inc. as the Exclusive U.S. Specialty Pharmacy for the Expanded Indication for IMCIVREE® (setmelanotide)	[ "PRNewswire" ]	[ "Rhythm Pharmaceuticals, Inc." ]	[ "PANTHERx® Rare" ]	[ { "phase": "Approved", "name": "IMCIVREE", "type": "Drug" } ]	[ "Collaboration" ]	null	[ "U.S." ]
国产首个！公司授权复星旗下公司乙肝-siRNA新药获美国FDA批准直接开展1b期临床	[ "News" ]	[ "上海赫吉亚生物医药有限责任公司" ]	[ "苏州星曜坤泽生物制药有限公司" ]	[ { "name": "HT-101注射液", "type": "Drug" } ]	[ "许可" ]	null	null
Granata Bio and IBSA Group Announce Strategic Partnership	[ "PRNewswire" ]	[ "IBSA Institut Biochimique SA" ]	[ "Granata Bio Inc" ]	[ { "phase": "Approved", "name": "progesterone , IBSA/Granata Bio", "type": "Drug" } ]	[ "许可" ]	null	[ "US" ]
Alexion Pharmaceuticals is partnering with Complement Pharma to co-develop a C6 complement inhibitor, CP010, for the treatment of neurodegenerative disorders.	[ "News" ]	[ "Complement Pharma" ]	[ "Alexion Pharmaceuticals" ]	[ { "phase": "Preclinical", "name": "CP010", "type": "Drug" } ]	[ "期权", "合作" ]	[ { "origin_value": "15.28百万美元", "type": "milestone_payment", "unit": "million dollars", "value": "15.28" } ]	null
Eurofarma Laboratórios SA acquires Laboratorio Medipharm	[ "NEWS" ]	[ "Laboratorio Medipharm" ]	[ "Eurofarma Laboratórios SA" ]	[ { "name": "Laboratorio Medipharm", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "35,999,813 USD", "type": "total_value", "unit": "million dollars", "value": "36.00" } ]	null
Université Laval and Glycovax Pharma Enter into an Exclusive Global License Agreement for the Development of Innovative Galectin-3 Inhibitors	[ "PRNewswire" ]	[ "Université Laval" ]	[ "Glycovax Pharma" ]	[ { "phase": "Discovery", "name": "Innovative Galectin-3 Inhibitors", "type": "Drug" } ]	[ "License" ]	null	[ "Global" ]
Exelixis, Inc. Signs Wyeth License Pact Worth Up To $157.5 Million	[ "NEWS" ]	[ "Exelixis" ]	[ "Wyeth" ]	[ { "phase": "Preclinical", "name": "compounds targeting the farnesoid X receptor", "type": "Drug" } ]	[ "许可" ]	[ { "origin_value": "147.5百万美元", "type": "milestone_payment", "unit": "million dollars", "value": "147.50" }, { "origin_value": "10百万美元", "type": "upfront_payment", "unit": "million dollars", "value": "10.00" } ]	null
Leadgene Biomedical, Inc. acquires Cytena Bioprocess Solutions	[ "NEWS" ]	[ "Cytena Bioprocess Solutions" ]	[ "Leadgene Biomedical, Inc." ]	[ { "name": "Cytena Bioprocess Solutions", "type": "Company" } ]	[ "企业收购" ]	null	null
Secarna Pharmaceuticals and Orbit Discovery Enter Collaboration to Discover and Develop Peptide-conjugated Targeted Antisense Oligonucleotide Therapeutics	[ "Biospace" ]	[ "Secarna Pharmaceuticals GmbH & Co. KG" ]	[ "Orbit Discovery Ltd." ]	[ { "phase": "Discovery-药物发现", "name": "Peptide-conjugated Targeted Antisense Oligonucleotide Therapeutics", "type": "Drug" } ]	[ "合作" ]	null	null
Solvay Pharmaceuticals and Wyeth Pharmaceuticals Sign Agreements to Co-Develop and Co-Commercialize CNS Compounds and Co-Promote EFFEXOR XR	[ "NEWS" ]	[ "Solvay Pharmaceuticals" ]	[ "Wyeth" ]	[ { "phase": "Phase 3 Clinical", "name": "bifeprunox", "type": "Drug" }, { "name": "four neuroscience compounds", "type": "Drug" } ]	[ "合作" ]	[ { "origin_value": "145.5百万美元", "type": "upfront_payment", "unit": "million dollars", "value": "145.50" } ]	null
Cline Scientific AB acquires Liv Diagnostics	[ "NEWS", "NEWS" ]	[ "Liv Diagnostics" ]	[ "Cline Scientific AB" ]	[ { "name": "Liv Diagnostics", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "5,201 USD", "type": "total_value", "unit": "million dollars", "value": "0.01" } ]	null
Lyell Immunopharma Completes Acquisition of ImmPACT Bio	[ "NEWS", "Company_Website", "GlobeNewswire", "NEWS" ]	[ "ImmPACT Bio USA Inc." ]	[ "Lyell Immunopharma, Inc." ]	[ { "name": "ImmPACT Bio USA Inc.", "type": "Company" }, { "phase": "Phase 1 Clinical-临床1期", "name": "IMPT-314", "type": "Drug" }, { "phase": "Preclinical-临床前", "name": "an activating TGF-beta Claudin 18.2 CAR T-cell candidate", "type": "Drug" } ]	[ "企业收购" ]	[ { "origin_value": "72,915,000 USD", "type": "total_value", "unit": "million dollars", "value": "72.92" }, { "origin_value": "$30 million", "type": "upfront_payment", "unit": "million dollars", "value": "30.0000" } ]	null
Stiefel, a GSK company, enters agreement with Welichem Biotech, Inc. to acquire a novel topical agent for psoriasis and atopic dermatitis	[ "PRNewswire" ]	[ "Welichem Biotech" ]	[ "施泰福大药厂" ]	[ { "phase": "Phase 2 Clinical", "name": "WBI-1001", "type": "Drug" } ]	[ "收购", "期权" ]	[ { "origin_value": "27.2百万美元", "type": "upfront_payment", "unit": "million dollars", "value": "27.20" } ]	[ "Global" ]
瑞博生物与齐鲁制药签订授权协议推进抗PCSK9小核酸新药的开发与商业化	[ "NEWS" ]	[ "苏州瑞博生物技术股份有限公司" ]	[ "齐鲁制药有限公司" ]	[ { "phase": "phase 1 clinical", "name": "RBD7022", "type": "Drug" } ]	[ "许可" ]	[ { "origin_value": "7亿元人民币", "type": "total_value", "unit": "million dollars", "value": "98.50" } ]	[ "中国" ]
ONO Enters an Agreement with IDAC Theranostics relating to Exclusive Evaluation and License Negotiation on IT1208, anti-CD4 antibody	[ "NEWS" ]	[ "IDAC Theranostics" ]	[ "盐野义制药株式会社" ]	[ { "phase": "Preclinical", "name": "IT1208", "type": "Drug" } ]	[ "期权" ]	null	null
Er-Kim Signs Exclusive Distribution Agreement with LEO Pharma A/S to Commercialize LOQTORZI® (toripalimab) for Nasopharyngeal and Oesophageal Cancers	[ "GlobeNewswire" ]	[ "LEO Pharma A/S" ]	[ "Er-Kim" ]	[ { "phase": "Approved", "name": "LOQTORZI", "type": "Drug" } ]	[ "Collaboration" ]	null	[ "Croatia", "Estonia", "Bulgaria", "Slovenia", "Lithuania", "Poland", "Hungary", "Romania", "Slovakia", "Czechia", "Latvia" ]
KLOX Technologies acquires FB Dermatology	[ "NEWS" ]	[ "FB Dermatology" ]	[ "KLOX Technologies" ]	[ { "name": "FB Dermatology", "type": "Company" } ]	[ "企业收购" ]	null	null
LG Life Sciences agreed to co-develop and commercialize Biosimilar product with Mochida Pharmaceutical	[ "NEWS", "NEWS" ]	[ "LG Chem" ]	[ "持田制药株式会社" ]	[ { "phase": "Phase 1 Clinical", "name": "LBAL", "type": "Drug" } ]	[ "合作" ]	null	[ "Japan" ]
Genovis exercised its call option to acquire the remaining 75% of SEQURNA	[ "Company_Website" ]	[ "SEQURNA AB" ]	[ "Genovis AB" ]	[ { "name": "SEQURNA AB", "type": "Company" } ]	[ "M&A" ]	[ { "origin_value": "SEK 52.5 million", "type": "milestone_payment", "unit": "million dollars", "value": "5.2347" } ]	null
Qualigen Therapeutics Secures Option to Negotiate License for G-Quadruplex Anti-Cancer Technology from UCL	[ "News" ]	[ "Qualigen Therapeutics" ]	[ "University College London" ]	[ { "phase": "Preclinical", "name": "AS1411-GNP", "type": "Drug" } ]	[ "期权", "许可" ]	null	[ "Global" ]
GSK taps Alnylam tech for faster vaccine production	[ "NEWS", "NEWS" ]	[ "Alnylam" ]	[ "GlaxoSmithKline" ]	[ { "name": "VaxiRNA platform", "type": "Technology/Platform" } ]	[ "License" ]	[ { "origin_value": "$3.2 million.", "type": "milestone_payment", "unit": "million dollars", "value": "3.2000" } ]	null
Sandoz has completed the acquisition of GSK's cephalosporin antibiotics business	[ "News" ]	[ "山德士制药有限公司" ]	[ "葛兰素史克制药" ]	[ { "phase": "Approved", "name": "Zinacef", "type": "Drug" }, { "phase": "Approved", "name": "Fortum", "type": "Drug" }, { "phase": "Approved", "name": "Zinnat", "type": "Drug" } ]	[ "许可" ]	null	null
CheckmAb announced the successful achievement of the second milestone in the collaboratton with Boehringer Ingelheim	[ "NEWS" ]	[ "CheckmAb S.r.l." ]	[ "Boehringer Ingelheim" ]	[ { "phase": "Discovery", "name": "monoclonal anttbody (mAb) for cancer immunotherapy", "type": "Drug" } ]	[ "License" ]	[ { "origin_value": "EUR 240 million", "type": "milestone_payment", "unit": "million dollars", "value": "248.0387" } ]	null
Guangdong Vtr Bio-Tech takes a minority stake in Changsha World-Way Biotech, Inc.	[ "NEWS", "NEWS" ]	[ "Changsha World-Way Biotech, Inc." ]	[ "Guangdong Vtr Bio-Tech" ]	[ { "name": "Changsha World-Way Biotech, Inc.", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "12,295,524 USD", "type": "total_value", "unit": "million dollars", "value": "12.30" } ]	null
Dimerix Bioscience Pty Ltd entered into a second research program with Takeda Cambridge Limited	[ "NEWS" ]	[ "Dimerix Bioscience Pty Ltd" ]	[ "Takeda Cambridge Limited" ]	[ { "phase": "Discovery", "name": "new drugs targeting GPCRS", "type": "Drug" } ]	[ "Collaboration" ]	null	null
圣和药业携手卡提医学进军细胞治疗领域	[ "NEWS" ]	[ "南京卡提医学科技有限公司" ]	[ "南京圣和药业股份有限公司" ]	[ { "name": "CAR-T细胞构建的专业技术平台", "type": "Technology/Platform" } ]	[ "合作" ]	null	null
亚宝药业携手印度鲁宾制药拓展中国儿科产品市场	[ "News" ]	[ "印度鲁宾有限公司" ]	[ "亚宝药业集团股份有限公司" ]	[ { "name": "儿科用药", "type": "Drug" } ]	[ "许可" ]	null	[ "中国" ]
Quartz Bio acquires Solve Inc	[ "NEWS" ]	[ "Solve Inc" ]	[ "Quartz Bio", "Precision Medicine Group" ]	[ { "name": "Solve Inc", "type": "Company" } ]	[ "企业收购" ]	null	null
Q-Med AB Agrees to Be Acquired by Galderma Pharma S.A. for $970 Million	[ "NEWS" ]	[ "Q-Med AB" ]	[ "高德美制药" ]	[ { "name": "Q-Med AB", "type": "Company" } ]	[ "企业收购" ]	[ { "origin_value": "750.96百万美元", "type": "total_value", "unit": "million dollars", "value": "750.96" } ]	null
Maverix Medical LLC acquires Cirrus Bio	[ "NEWS" ]	[ "Cirrus Bio" ]	[ "Hologic, Inc.", "Kohlberg Kravis Roberts & Co. LP", "Maverix Medical LLC", "Ajax Health LLC" ]	[ { "name": "Cirrus Bio", "type": "Company" } ]	[ "企业收购" ]	null	null
Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430	[ "NEWS" ]	[ "Kate Therapeutics" ]	[ "安斯泰来制药" ]	[ { "phase": "临床前", "name": "KT430", "type": "Drug" } ]	[ "许可" ]	null	null
Trek Therapeutics Acquires Two Antiviral Inhibitors From Vertex Pharmaceuticals	[ "News" ]	[ "Vertex Pharmaceuticals" ]	[ "Trek Therapeutics" ]	[ { "phase": "Phase 2 Clinical", "name": "VX-222", "type": "Drug" }, { "phase": "Phase 2 Clinical", "name": "VX-497", "type": "Drug" } ]	[ "许可" ]	null	[ "Global" ]
中国科学院上海药物研究所与海和药物合作开展溴结构域蛋白（BRD4）抑制剂的合作研究	[ "News" ]	[ "上海海和药物研究开发股份有限公司" ]	[ "中国科学院上海药物研究所" ]	[ { "phase": "Preclinical", "name": "HH3567", "type": "Drug" } ]	[ "合作" ]	null	null
Y-mAbs Announces Partnership Regarding Early Access Program for DANYELZA (naxitamab-gqgk) in Europe	[ "News", "News" ]	[ "Y-mAbs Therapeutics" ]	[ "WEP Clinical" ]	[ { "phase": "Approved", "name": "DANYELZA®", "type": "Drug" } ]	[ "许可" ]	null	[ "欧洲" ]
Tervetuloa Orionin uutishuoneeseen, josta löydät uusimmat tiedotteet ja ajankohtaiset artikkelit.	[ "News" ]	[ "CuraTeQ Biologics" ]	[ "芬兰奥利安集团" ]	[ { "phase": "Phase 3 Clinical", "name": "CuraTeQ’s biosimilars", "type": "Drug" } ]	[ "合作", "许可" ]	null	null
Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program	[ "NEWS" ]	[ "Amira Pharmaceuticals" ]	[ "葛兰素史克制药" ]	[ { "name": "FLAP inhibitors", "type": "Drug" }, { "name": "AM103", "type": "Drug" } ]	[ "许可" ]	[ { "origin_value": "425百万美元", "type": "upfront_payment", "unit": "million dollars", "value": "425.00" } ]	[ "Global" ]
SORRENTO AND THE UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON ENTER INTO PRECLINICAL TESTING AGREEMENT FOR COVID-19 THERAPEUTIC CANDIDATES	[ "NEWS" ]	[ "University of Texas Medical Branch at Galveston" ]	[ "Sorrento Therapeutics Inc" ]	[ { "phase": "preclinical", "name": "ACE-MAB , Mabpharm/Sorrento Therapeutics", "type": "Drug" } ]	[ "合作" ]	null	null
IsomAb Announces Nomination of Development Candidate for Peripheral Arterial Disease and Strategic Collaboration with Pfizer	[ "PRNewswire" ]	[ "IsomAb Ltd" ]	[ "Pfizer" ]	[ { "name": "ISM-001", "type": "Drug" } ]	[ "collaboration" ]	null	null
Bioasis Technologies Inc. Announces Termination of Arrangement Agreement with Midatech Pharma plc	[ "GlobeNewswire" ]	[ "BIOASIS TECHNOLOGIES INC." ]	[ "Midatech Pharma plc" ]	[ { "name": "Bioasis Technologies", "type": "Company" } ]	[ "企业收购" ]	null	null
GARDP and BioVersys will sign an MOU to collaborate on the development of antibiotics, including BV-100, for treating paediatric bacterial infections.	[ "NEWS" ]	[ "Global Antibiotic Research and Development Partnership" ]	[ "BioVersys AG" ]	[ { "phase": "Preclinical", "name": "BV-100", "type": "Drug" } ]	[ "合作" ]	null	null
Intec Pharma Announces Research Collaboration Agreement With Merck	[ "News" ]	[ "Intec Pharma" ]	[ "默沙东制药" ]	[ { "name": "Accordion Pill ® (AP) platform", "type": "Technology/Platform" } ]	[ "合作" ]	null	null
Crescita Announces Licensing Agreement for Pliaglis® in China	[ "NEWS" ]	[ "Crescita Therapeutics Inc" ]	[ "Juyou Bio-Technology Co Ltd" ]	[ { "phase": "Approved", "name": "lidocaine + tetracaine , Nuvo", "type": "Drug" } ]	[ "许可" ]	[ { "origin_value": "2.8 million 美元", "type": "milestone_payment", "unit": "million dollars", "value": "2.80" }, { "origin_value": "2.925 million 美元", "type": "total_value", "unit": "million dollars", "value": "2.93" }, { "origin_value": "0.125 million 美元", "type": "upf...	[ "China" ]

End of preview. Expand in Data Studio

🤝 Dataset Summary

Pharmaceutical licensing and deal intelligence records covering 1,000 transactions. Each record captures the deal structure, involved organizations, financial terms, and asset details, sourced from news and company disclosures.

🚀 Key Features

Deal Structure: deal_type classifies transaction type (license, acquisition, collaboration, etc.) with multilingual labels.
Financial Terms: deal_value provides structured breakdown of payment types (upfront, milestone) with normalized USD values (~34.5% of records).
Organizational Mapping: principle_org and partner_org identify both sides of each transaction.
Asset Linkage: deal_project links deals to specific drugs or programs by name and type.
Territory Coverage: territory_included specifies geographic rights where disclosed (~33.8% of records).

💻 Quick Start & MCP Integration

from datasets import load_dataset

dataset = load_dataset("your-org/drug-deals", split="train")
record = dataset[0]
print(record["deal_title"])
# Output: 'GSK exercises option on Anacor\'s novel antibiotic for the treatment of gram-negative infections'
print(record["principle_org"])
# Output: ['Anacor Pharmaceuticals']
print(record["deal_value"][0]["value"])
# Output: '15.00'  (million dollars, upfront payment)

Downloads last month: 30